MK
MERCK Kommanditgesellschaft auf Aktien
MKGAF · OTC
$166.60 +1.77% (+$2.89)
1M -4.71%
Market Cap 60.4B €
P/E Ratio 25.48x
Div. Yield 1.59%
ROE 7.75%
Bulios Fair Price
$98.63
40.8% downside
Trenutna cena
$166.6
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica MKGAF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
65 /100
Fair P/E 25.48x
P/B 2.01x
EV/EBITDA 10.23x
Growth
13 /100
Declining EPS growth 7.78%
Book val. growth 3.30%
Rev. growth 1.74%
Profitability
83 /100
Strong Gross margin 58.70%
FCF margin 13.83%
Net margin 11.22%
Quality
38 /100
Average ROIC 7.18%
Asset turnover 0.40x
ROE 7.75%
Debt
82 /100
Low Debt/Equity 0.41x
Net debt/EBITDA 1.49x
Current ratio 1.69x
Stability
100 /100
Stable Beta 0.83x
Profitable years 6
Rev. volatility 3.40%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MKGAF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Kai Beckmann
Employees
62,461
Headquarters
Darmstadt
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report